Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
Oren Livnat Reiterated (AVDL) at Strong Buy and Held Target at $13 on, Feb 7th, 2023
Oren Livnat of HC Wainwright & Co., Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy and Held Target at $13 on, Feb 7th, 2023.
Oren has made no other calls on AVDL in the last 4 months.
There is 1 other peer that has a rating on AVDL. Out of the 1 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Chris Howerton of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $11 on, Wednesday, November 30th, 2022
